Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer.
Aiko YamaguchiArifudin AchmadHirofumi HanaokaYusri Dwi HeryantoAnu Bhattarainull RatiantoErdene KhongorzulRini ShintawatiA Adhipatria P KartamihardjaAyaka KanaiYumi SugoNoriko S IshiokaTetsuya HiguchiYoshito TsushimaPublished in: BMC cancer (2019)
Our findings suggest that this immuno-PET imaging can be clinically translated as a tool to predict cetuximab accumulation in NSCLC cancer patients prior to cetuximab therapy.